Advanced Technology
Major advancements in the science of dermatology products for dogs and cats are the results of on-going research and development.
Glycotechnology
The patent-pending anti-adhesive technology that inhibits bacteria such as Staphylococcus and Pseudomonas, and yeast such as, Malassezia, from adhering to the skin surface. Glycotechnology reduces keratinocyte activation and cytokine production, which is key to preventing and disrupting inflammation associated with bacterial infections and allergens.
SPHERULITES® Microcapsules, an exclusive encapsulation system
Concentric-layered patented microspheres which release specific ingredients as the layers gradually breakdown, providing a sustained effect.
Magnification of SPHERULITES® Microcapsules, an exclusive encapsulation system binding to hair shaft
There are two types of SPHERULITES® Microcapsules:
Non-ionic deep action (not charged), which penetrate into the different skin structures.
Cationic surface action (positively charged), which bind to the negatively charged surface skin.
Success rates of treatment are based on three criteria:
Compliance - SPHERULITES® Microcapsules with their time release of ingredients help in removing compliance as an obstacle to effective treatment.
Persistence - SPHERULITES® Microcapsules through their persistent activity on the skin and hair coat enhance contact time.
Efficacy - Enhance efficacy through increased contact time of ingredients used in topical therapy.
SPHERULITES® Microcapsules effectively combine these three components to yield longer lasting results and greater pet owner satisfaction.